Unit - 1 As
Unit - 1 As
Unit - 1 As
CONSTRUCTION
It consists of a cylindrical balloon that sits in the aorta and
counterpulsates. That is, it actively deflates in systole increasing
forward blood flow by reducing afterload thus, and actively
inflates in diastole increasing blood flow to the coronary
arteries.
These actions have the combined result of decreasing
myocardial oxygen demand and increasing myocardial oxygen
supply.
The balloon is inflated during diastole by a computer controlled
mechanism, usually linked to either an ECG or a pressure
transducer at the distal tip of the catheter.
Helium is used because its low viscosity allows it to travel
quickly through the long connecting tubes, and has a lower risk
of causing a harmful embolism should the balloon rupture while
in use.
Whereas carbon dioxide has an increased solubility in blood and
thereby reduces the potential consequences of gas embolization
following a balloon rupture.
INSERTION TECHNIQUE
In the early years of IABP - therapy, insertion of the balloon
was performed by surgical cut down to the femoral vessels.
a percutaneous placement of the IAB via the femoral artery
using a modified Seldinger technique allows an easy and rapid
insertion in the majority of situations.
sheathless insertion kits are available now. Removal of a
percutaneously placed IAB may either be via surgical removal
or closed technique
The most common strategy for inserting an intraaortic balloon
pump (IABP) is a catheter-based procedure.
Just prior to the procedure, the area to receive the catheter is
shaved (if necessary) and sterilized to prevent infection.
WORKING
By increasing cardiac output it also increases coronary blood
flow and therefore myocardial oxygen delivery.
It consists of a cylindrical balloon that sits in the aorta and
counterpulsates. That is, it actively deflates in systole increasing
forward blood flow by reducing afterload.
actively inflates in diastole increasing blood flow to
the coronary arteries.
These actions have the combined result of decreasing
myocardial oxygen demand and increasing myocardial oxygen
supply
TRIGGERING
Inflation and deflation is accomplished by either using the
patient’s ECG signal, the patient’s arterial waveform or an
intrinsic pump rate.
The most common method of triggering the IAB is from the R
wave of the patient’s ECG signal.
Mainly balloon inflation is set automatically to start in the
middle of the T wave and to deflate prior to the ending QRS
complex.
Tachyarrhythmias, cardiac pacemaker function and poor ECG
signals may cause difficulties in obtaining synchronization when
the ECG mode is used. In such cases the arterial waveform for
triggering may be used.
TIMING AND WEANING
It is important that the inflation of the IAB occurs at the
beginning of diastole, noted on the dicrotic notch on the arterial
waveform.
Deflation of the balloon should occur immediately prior to the
arterial upstroke.
Balloon synchronization starts usually at a beat ratio of 1:2. This
ratio facilitates comparison between the patient’s own
ventricular beats and augmented beats to determine ideal IABP
timing.
If the patient’s cardiac performance improves, weaning from the
IABP may begin by gradually decreasing the balloon
augmentation ratio (from 1:1 to 1:2 to 1:4 to 1:8) under control
of hemodynamic stability
INDICATIONS
The following situations may benefit from this device:
Cardiogenic shock when used alone as treatment for myocardial
infarction 9-22% survive the first year.
Reversible intracardial mechanical defects complicating
infarction, i.e. acute mitral regurgitation and septal perforation.
Unstable angina pectoris benefits from counterpulsation.
Percutaneous coronary angioplasty.
assist in complicated balloon angioplasty procedures and
various other cardiac situations.
Cardiac patients requiring procedural support during coronary
angiography.
Post cardiothoracic surgery most common and useful is the use
of counterpulsation in weaning patients from cardiopulmonary
bypass after continued perioperative injury to myocardial tissue.
Preoperative use has been suggested for high-risk patients such
as those with unstable angina with stenosis greater than 70% of
main coronary artery, in ventricaular dysfunction with
an ejection fraction less than 35%.
Bridge to heart transplant for those patients with left ventricular
failure.
wean patients off the heart-lung machine during open-heart
surgery.
CONTRAINDICATIONS
• Aortic valve insufficiency.
• Aortic dissection.
• Severe aortoiliac occlusive disease.
• Prosthetic vascular grafts in the aorta.
• Aortic aneurysm.
• Aortofemoral grafts.
• Irreversible brain damage.
• Severe vascular disease
LONGEVITY
• The intraaortic balloon pump (IABP) usually remains implanted
for a short period of time, such as in the following situations:
• Before, during or after open-heart surgery or balloon
angioplasty (in high-risk patients)
• During acute attacks of angina
• In emergency situations (e.g., heart attack, heart failure, very
low blood pressure due to cardiogenic shock)
BENEFITS
The IABP offers the following potential benefits:
Improved circulation
Lower heart rate and decreased workload of the heart
Improved efficiency of the heart’s pumping
Increased supply of oxygen to heart tissues and decreased
demand for it
Less pressure resistance in the aorta when the heart pumps
(during the systole)
More pressure in the aorta when the heart is relaxing, thus
increasing blood flow to the heart muscle (during the diastole)
RISKS
some complications that are reported in some patients include:
Damage to the aorta or femoral artery
Heavy bleeding (hemorrhaging), occasionally from the site of
insertion
Infection
Lack of oxygen-rich blood to either a limb (limb ischemia) or an
organ (visceral ischemia), due to narrowed blood vessels
Tearing or bursting of the balloon, releasing gas into the
bloodstream with potentially dangerous results
Coronory
Filter Coronary Sinus
Pump Receiving Pump
Reservoir
Arterial
Pump Oxygenator
FUNCTIONS
• LUNGS--------- OXYGENATOR
• HEART--------- PUMPS
OXYGENATORS
• For Oxygenation of Blood, upto 5 l/min of blood.
• Ideal oxygenation req:
1. Lower Priming Volume.
2. Simple,Safe ,Reliable operation.
3. Short preparation time.
4. No Microembolus formation.
Types of Oxygenators
• BUBBLE OXYGENATOR
• FILM OXYGENATOR
• MEMBRANE OXYGENATOR
• LIQUID-LIQUID OXYGENATOR
BUBBLE OXYGENATOR-
Principle
• Oxygen is bubbled through a large column of blood and made to
flow through a slanting path to remove Carbon dioxide.
Co2
Filter
O2 Blood
DESCRIPTION
Two components
1.Oxygen is bubbled in finely dispersed form
2. Gas separating component- gaseous exchange
takes place
Bubbles and foam are removed-if bubbles present causes
air emboli, to remove it defoaming agent like silicon is used.
Types::
1.Permanent type
2.Disposable type
DISC TYPE FILM OXYGENATOR
O2
CO2
Blood Blood
Film oxygenator
• A thin film of blood is spread on a rotating disc or a metal
screen and oxygen mixture flows over it.
TYPES:::
1.FOAM::: Blood is poured on top of the blood foam
and oxygen mixture is bubbled through it in opposite direction.
Blood spreads over the surface of the bubble in a thin
form and it is exposed to oxygen.the filmed blood is oxygenated
2.SCREEN TYPE:::
1.A thin film of blood over a screen is exposed to oxygen.
* Disposable.
3.BLOOD FILM OVERSPONGE
1. A small volume of sponges saturated with blood provides a
large surface area if oxygen is distributed in the sponge.
* Artificial alveoli
. ROTATING DISC FILM OXYGENATOR:::
1.Rotating disc are present as vertical lines.
2.Blood level is maintained at the bottom of the cylinder
so that only the outer edge is immersed in the blood.
3.Rotation of the cylinder causes a thin film to form the
periphery of the disc ,after short exposure the blood is washed off
and a new film is formed on it it is also washed off.
4. Exposure of blood film is only for shorter period.
MEMBRANE OXYGENATOR
• PRINCIPLE:
Effective oxygenation is done when blood and oxygen are
running in opposite direction through a thin porous membrane
Blood Blood
Membrane
CO2 O2
Metal mesh
CONCLUSION
Many people have benefited from prosthetic heart valves over the past
30 years. Chemical engineers believe that the future of prosthetic
valves lies in the regime of tissue engineering. This would improve
the biocompatibily factor, and increase the life expectancy of the heart
valve.